InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

68
Insider
Date
Role
Action
Shares
Price
Amount
Kevin McCulloch
2 Nov 2026
See Remarks
Sold on a plan
15,000
$10.23
$153.49K
Beth Hecht
2 Nov 2026
See Remarks
Sold on a plan
25,000
$10.23
$255.83K
Steven Pieper
2 Nov 2026
See Remarks
Sold on a plan
5,000
$10.23
$51.17K
Beth Hecht
1 Oct 2026
See Remarks
Sold on a plan
16,666
$9.41
$156.79K
Kevin McCulloch
1 Oct 2026
See Remarks
Sold on a plan
15,000
$9.41
$141.12K
Steven Pieper
1 Oct 2026
See Remarks
Sold on a plan
5,000
$9.41
$47.04K
Kevin McCulloch
28 Sep 2026
See Remarks
Sold on a plan
25,000
$10.00
$250.00K
Steven Pieper
1 Sep 2026
See Remarks
Sold on a plan
5,000
$8.50
$42.50K
Beth Hecht
1 Sep 2026
See Remarks
Sold on a plan
16,666
$8.49
$141.43K
Kevin McCulloch
1 Sep 2026
See Remarks
Sold on a plan
15,000
$8.49
$127.31K
Steven Pieper
12 Aug 2026
See Remarks
Sold on a plan
5,000
$8.50
$42.50K
Beth Hecht
3 Aug 2026
See Remarks
Sold on a plan
16,666
$8.01
$133.55K
Kevin McCulloch
3 Aug 2026
See Remarks
Sold on a plan
15,000
$8.02
$120.24K
Steven Pieper
7 Jul 2026
See Remarks
Sold on a plan
27,600
$8.52
$235.28K
Steven Pieper
6 Jul 2026
See Remarks
Sold on a plan
17,400
$8.50
$147.90K
Beth Hecht
1 Jul 2026
See Remarks
Sold on a plan
16,666
$8.03
$133.86K
Kevin McCulloch
1 Jul 2026
See Remarks
Sold on a plan
90,000
$8.03
$722.51K
John Johnson
4 Jun 2026
Director
Sold on a plan
15,000
$6.09
$91.42K
Barbara-Jean Anne Bormann-Kennedy
4 Jun 2026
Director
Sold on a plan
16,000
$6.09
$97.51K
Dawn Halkuff
4 Jun 2026
Director
Sold on a plan
20,000
$6.09
$121.89K
Marla Persky
3 Jun 2026
Director
Sold on a plan
15,500
$5.90
$91.43K
Beth Hecht
1 Jun 2026
See Remarks
Sold on a plan
16,667
$6.06
$100.98K
Beth Hecht
1 May 2026
See Remarks
Sold on a plan
16,667
$6.23
$103.81K
Beth Hecht
1 Apr 2026
See Remarks
Sold on a plan
16,667
$5.99
$99.86K
James Aloysius Brady
30 Mar 2026
Director
Sold on a plan
10,834
$5.54
$60.04K
Kevin McCulloch
12 Mar 2026
See Remarks
Exercised, kept
4
$3.94
$15.76
Kevin McCulloch
12 Mar 2026
See Remarks
Exercised, kept
48,894
$4.09
$199.98K
Steven Pieper
5 Mar 2026
See Remarks
Exercised, kept
14,036
$5.93
$83.23K
Steven Pieper
5 Mar 2026
See Remarks
Exercised, kept
27,891
$4.09
$114.07K
Beth Hecht
2 Mar 2026
See Remarks
Sold on a plan
100
$7.06
$706.00
Beth Hecht
2 Mar 2026
See Remarks
Sold on a plan
16,567
$6.24
$103.38K
Beth Hecht
2 Feb 2026
See Remarks
Sell
16,667
$7.45
$124.15K
Kevin McCulloch
8 Jan 2026
See Remarks
Sold on a plan
15,000
$8.00
$120.00K
John Patrick Shannon Jr
5 Jan 2026
See Remarks
Sold after exercise
24,907
$7.08
$176.26K
Beth Hecht
2 Jan 2026
See Remarks
Sold on a plan
16,667
$7.43
$123.78K
John Johnson
19 Dec 2025
Director
Sell
135,400
$7.22
$977.02K
Barbara-Jean Anne Bormann-Kennedy
12 Dec 2025
Director
Sold on a plan
15,000
$7.09
$106.41K
Beth Hecht
1 Dec 2025
See Remarks
Sold on a plan
16,667
$7.01
$116.78K
John Patrick Shannon Jr
14 Nov 2025
See Remarks
Exercised, kept
87,100
$1.55
$135.01K
John Patrick Shannon Jr
13 Nov 2025
See Remarks
Sold after exercise
23,242
$7.46
$173.40K
Beth Hecht
11 Nov 2025
See Remarks
Sold on a plan
16,667
$7.40
$123.30K
Marla Persky
11 Sep 2025
Director
Sold on a plan
15,500
$7.72
$119.61K
Jeffrey W Sherman
28 Aug 2025
Director
Sold after exercise
42,232
$7.92
$334.52K
John Johnson
13 Aug 2025
Director
Sell
107,500
$7.32
$786.46K
Dawn Halkuff
12 Aug 2025
Director
Sell
42,500
$7.28
$309.23K
Kevin McCulloch
13 Jun 2025
See Remarks
Buy
25,000
$4.38
$109.48K
Beth Hecht
20 Mar 2025
See Remarks
Sell
40,000
$5.43
$217.24K
Steven Pieper
22 Nov 2024
See Remarks
Exercised, kept
19,483
$1.55
$30.20K
John P. Schmid
12 Aug 2024
Director
Buy indirect
4,515
$2.25
$10.15K
John P. Schmid
9 Aug 2024
Director
Buy indirect
4,285
$2.37
$10.13K
John P. Schmid
10 May 2024
Director
Buy indirect
5,400
$1.91
$10.31K
John Johnson
18 Mar 2024
Director
Exercised, kept
215,600
$1.99
$429.04K
John P. Schmid
14 Mar 2024
Director
Buy indirect
4,500
$2.16
$9.72K
Jeffrey W Sherman
27 Nov 2023
Director
Buy indirect
5,400
$1.87
$10.10K
Steven Pieper
20 Nov 2023
See Remarks
Buy
28,000
$1.95
$54.60K
Dawn Halkuff
20 Nov 2023
Director
Buy indirect
5,410
$1.84
$9.95K
John Patrick Shannon Jr
17 Nov 2023
See Remarks
Buy
30,769
$1.64
$50.40K
John P. Schmid
16 Nov 2023
Director
Buy indirect
6,500
$1.51
$9.82K
Marla Persky
14 Nov 2023
Director
Buy indirect
6,370
$1.58
$10.06K
Paul R Edick
9 Aug 2023
See Remarks
Buy
10,000
$2.38
$23.79K
Paul R Edick
13 Dec 2022
See Remarks
Buy
20,000
$1.45
$29.00K
Paul R Edick
12 May 2022
See Remarks
Buy
100,000
$1.40
$140.38K
Steven Prestrelski
22 Feb 2022
Chief Scientific Officer
Sold after exercise
11,228
$2.42
$27.16K
Paul R Edick
15 Nov 2021
See Remarks
Buy indirect
20,000
$2.28
$45.66K
John Patrick Shannon Jr
12 Nov 2021
See Remarks
Buy
60,000
$2.10
$126.00K
Paul R Edick
11 Nov 2021
See Remarks
Buy
200,000
$2.08
$415.76K
John Patrick Shannon Jr
11 Nov 2021
See Remarks
Buy
40,000
$2.09
$83.50K
Steven Pieper
10 Nov 2021
See Remarks
Buy
25,000
$2.00
$49.92K

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 17,798,318
History held since 5 Oct 2021